Fibrolamellar carcinomas show overexpression of genes in the RAS, MAPK, PIK3, and xenobiotic degradation pathways

Human Pathology

Volumn 38, Issue 4, 2007, Pages 639-644

  Kannangai, Rajesh ^a   Vivekanandan, Perumal ^b   Martinez Murillo, Francisco ^b   Choti, Michael ^b   Torbenson, Michael ^b  

^a CHRISTIAN MEDICAL COLLEGE   (India)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Chromosome 1q; Fibrolamellar carcinoma; MAPK; PIK3; RAS; Xenobiotic degradation pathways

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; CNIH4 PROTEIN; ENSA PROTEIN; FH PROTEIN; MEMBRANE COFACTOR PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; NICE 3 PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PSMB4 PROTEIN; RGS2 PROTEIN; RGS5 PROTEIN; TIMM17A PROTEIN; UFC1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CHROMOSOME 1Q; CONTROLLED STUDY; DNA MICROARRAY; FIBROLAMELLAR CARCINOMA; GENE LOCATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; METASTASIS; ONCOGENE RAS; REAL TIME POLYMERASE CHAIN REACTION; XENOBIOTIC METABOLISM;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MALE; MAP KINASE SIGNALING SYSTEM; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; SIGNAL TRANSDUCTION; UP-REGULATION; XENOBIOTICS;

EID: 33947149044     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.07.019     Document Type: Article

References (18)

1. Sirivatanauksorn Y., Sirivatanauksorn V., Lemoine N.R., Williamson R.C., and Davidson B.R. Genomic homogeneity in fibrolamellar carcinomas. Gut 49 (2001) 82-86
2. Marchio A., Pineau P., Meddeb M., et al. Distinct chromosomal abnormality pattern in primary liver cancer of non-B, non-C patients. Oncogene 19 (2000) 3733-3738
3. Lowichik A., Schneider N.R., Tonk V., Ansari M.Q., and Timmons C.F. Report of a complex karyotype in recurrent metastatic fibrolamellar hepatocellular carcinoma and a review of hepatocellular carcinoma cytogenetics. Cancer Genet Cytogenet 88 (1996) 170-174
4. Wilkens L., Bredt M., Flemming P., Kubicka S., Klempnauer J., and Kreipe H. Cytogenetic aberrations in primary and recurrent fibrolamellar hepatocellular carcinoma detected by comparative genomic hybridization. Am J Clin Pathol 114 (2000) 867-874
5. Leung T.H., Wong N., Lai P.B., et al. Identification of four distinct regions of allelic imbalances on chromosome 1 by the combined comparative genomic hybridization and microsatellite analysis on hepatocellular carcinoma. Mod Pathol 15 (2002) 1213-1220
6. Hung C.J., Ginzinger D.G., Zarnegar R., et al. Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors. J Clin Endocrinol Metab 88 (2003) 3694-3699
7. Lapis K., Schaff Z., Kopper L., Karacsonyi S., and Ormos J. Fibrolamellar liver carcinoma. Zentralbl Allg Pathol 136 (1990) 135-149
8. Payne C.M., Nagle R.B., Paplanus S.H., and Graham A.R. Fibrolamellar carcinoma of liver: a primary malignant oncocytic carcinoid?. Ultrastruct Pathol 10 (1986) 539-552
9. Hany M.A., Betts D.R., Schmugge M., et al. A childhood fibrolamellar hepatocellular carcinoma with increased aromatase activity and a near triploid karyotype. Med Pediatr Oncol 28 (1997) 136-138
10. Agarwal V.R., Takayama K., Van Wyk J.J., Sasano H., Simpson E.R., and Bulun S.E. Molecular basis of severe gynecomastia associated with aromatase expression in a fibrolamellar hepatocellular carcinoma. J Clin Endocrinol Metab 83 (1998) 1797-1800
11. Collier N.A., Weinbren K., Bloom S.R., Lee Y.C., Hodgson H.J., and Blumgart L.H. Neurotensin secretion by fibrolamellar carcinoma of the liver. Lancet 1 (1984) 538-540
12. Ehrenfried J.A., Zhou Z., Thompson J.C., and Evers B.M. Expression of the neurotensin gene in fetal human liver and fibrolamellar carcinoma. Ann Surg 220 (1994) 484-489 [discussion 489-491]
13. Ding S.F., Delhanty J.D., Bowles L., Dooley J.S., Wood C.B., and Habib N.A. Infrequent chromosome allele loss in fibrolamellar carcinoma. Br J Cancer 67 (1993) 244-246
14. Wong N., Chan A., Lee S.W., et al. Positional mapping for amplified DNA sequences on 1q21-q22 in hepatocellular carcinoma indicates candidate genes over-expression. J Hepatol 38 (2003) 298-306
15. Chen X., Higgins J., Cheung S.T., et al. Novel endothelial cell markers in hepatocellular carcinoma. Mod Pathol 17 (2004) 1198-1210
16. Furuya M., Nishiyama M., Kimura S., et al. Expression of regulator of G protein signalling protein 5 (RGS5) in the tumour vasculature of human renal cell carcinoma. J Pathol 203 (2004) 551-558
17. + hematopoietic stem/progenitor cells. Genome Res 10 (2000) 1546-1560
18. Wang H., Craig R.L., Schay J., et al. Alpha-endosulfine, a positional and functional candidate gene for type 2 diabetes: molecular screening, association studies, and role in reduced insulin secretion. Mol Genet Metab 81 (2004) 9-15